Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Weller Michael, Butowski Nicholas, Tran David D., Recht Lawrence D., Lim Michael, Hirte Hal, Ashby Lynn, Mechtler László, Goldlust Samuel A., Iwamoto Fabio, Drappatz Jan, O’Rourke Donald M., Wong Mark, Hamilton Mark G., Hideghéty Katalin (kollab. közrem.): Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
LANCET ONCOLOGY, 18 (10). pp. 1373-1385. ISSN 1470-2045 (2017)

[img]
Preview
Text
1_s2.0_S147020451730517X_main_u.pdf - Published Version

Download (476kB) | Preview
Item Type: Article
Journal or Publication Title: LANCET ONCOLOGY
Date: 2017
Volume: 18
Number: 10
Page Range: pp. 1373-1385
ISSN: 1470-2045
Faculty: Általános Orvostudományi Kar
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3333369
DOI id: https://doi.org/10.1016/S1470-2045(17)30517-X
Date Deposited: 2018. Feb. 12. 15:00
Last Modified: 2018. Feb. 12. 15:00
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12926

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year